Danaher
DHR · NYSE
Bulios Fair Price
$147.92
30.4% downside
Current Price
$212.48
According to Bulios Fair Price, DHR is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Danaher Corporation (DHR) is an American global technology company with a portfolio of control and diagnostic tools, industrial technologies, and consumer products. The company focuses on providing innovative solutions to improve performance and efficiency across various industries. Danaher operates in four main segments: Life Sciences, Diagnostics, Environmental, and Industrial Technologies. Their diagnostic solutions include highly advanced medical instruments and diagnostic devices that support improved healthcare. The company is known for its precise and reliable industrial technologies that serve a wide range of applications. With its diverse portfolio and global reach, Danaher Corporation holds a strong position in the market. Shares of Danaher Corporation (DHR) could be an attractive investment opportunity for those seeking investments in the technology sector with an emphasis on diagnostics and industrial innovations.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Rainer Blair
Employees
59,000
Headquarters
Washington
Upcoming events
Ex-Dividend
Ex-dividend date
Earnings
Upcoming earnings report
Dividend Payment
Payment date